NCT05013957View on ClinicalTrials.gov

Neuroendocrine Neoplasms Methylation Based Classifier - The NEMESIs-study

CompletedOBSERVATIONAL
Enrollment

32

Participants

Timeline

Start Date

January 1, 2022

Primary Completion Date

December 30, 2024

Study Completion Date

December 30, 2024

Conditions
Neuroendocrine Tumors
Interventions
DIAGNOSTIC_TEST

Methylation analysis

Methylation analysis

Trial Locations (1)

4031

University Hospital Basel, Department of Endocrinology, Basel

All Listed Sponsors
lead

University Hospital, Basel, Switzerland

OTHER

NCT05013957 - Neuroendocrine Neoplasms Methylation Based Classifier - The NEMESIs-study | Biotech Hunter | Biotech Hunter